← brief for 2026-09-22 · Slowing decline

A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease

Trial No results yet Not peer reviewed

Key takeaways

This study is testing a pill called roxadustat in children with kidney disease. It aims to treat low red blood cell counts, or anemia. The study will last up to 52 weeks. There are no results yet.

Who did this work

Run by Astellas Pharma Global Development, Inc.. Medical Monitor (Astellas Pharma Global Development, Inc.)
Sites: Site BE32002 · Site BE32005 · Site BE32001 · Site BE32004 · Site BE32003 · Site BG35901

Source

Trial · ClinicalTrials.gov, CKD recruiting · 2026-09-22
https://clinicaltrials.gov/study/NCT05970172